← Back to Search

Nutritional Supplement

Creatine monohydrate for Depression

Phase 4
Waitlist Available
Led By Perry Renshaw, MD, PhD, MBA
Research Sponsored by Perry Renshaw
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female gender, ages 18-55 inclusive
Current primary diagnosis of MA dependence or abuse, with MA preferred drug of abuse
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-weeks
Awards & highlights

Study Summary

This trial proposes to study if the nutritional supplement creatine has an effect on the brain chemical phosphocreatine in women with methamphetamine addiction, in order to help with the substantial harm that it causes.

Eligible Conditions
  • Depression
  • Dual Diagnosis
  • Substance Addiction

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hamilton Depression Rating Scale (HAMD) scores
Secondary outcome measures
Beck Anxiety Inventory (BAI) scores
Other outcome measures
Neurochemistry measured by magnetic resonance spectroscopy

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Creatine monohydrateActive Control1 Intervention
5 grams of daily creatine monohydrate for 8 weeks
Group II: Healthy ControlActive Control1 Intervention
Group III: PlaceboPlacebo Group1 Intervention
5 g of placebo for 8 weeks

Find a Location

Who is running the clinical trial?

Perry RenshawLead Sponsor
6 Previous Clinical Trials
250 Total Patients Enrolled
4 Trials studying Depression
131 Patients Enrolled for Depression
Perry Renshaw, MD, PhD, MBAPrincipal Investigator - University of Utah
VA Salt Lake City Health Care System
University Of Pennsylvania School Of Medicine (Medical School)
Mass Gen Hospital (Residency)
2 Previous Clinical Trials
28 Total Patients Enrolled
2 Trials studying Depression
28 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Mar 2025